They do, throughout the entire development process, but PAR previously mentioned organising a Type D meeting with the FDA for DMOAD discussions. I don't think PAR can successfully request a Type B or C meeting yet. It's possible for PAR to request a second Type D meeting after the first one, but each meeting takes 50 or 60 days to organise and that's assuming that the FDA grants it.
Kumagai, one of the Fantastic Four and some Mozz Firsts..., page-50
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $206.0K | 1.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 217901 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 57971 | 5 |
View Market Depth
| Last trade - 15.09pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |